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Abstract
Background Traditionally, ultrasound (US)-guided bowel mass biopsies are avoided in favour of endoscopic or surgical biopsies.
However, endoscopy cannot easily reach lesions between the duodenojejunal flexure and the terminal ileum and lesions not
involving the mucosa may not be accessible via an endoscopic route.
Objective The aim of this study was to report our technique and to assess the diagnostic accuracy and safety of US-guided biopsy
of bowel masses in children.
Materials and methods We conducted a 14-year retrospective review of US-guided bowel mass biopsies at a single
paediatric hospital.
Results Twenty US-guided bowel mass biopsies were performed in 19 patients (median age: 6 years and 6months, range: 22months–
17 years, median weight: 22 kg, range: 10.2–48.4 kg). For 14 biopsies, there was no other lesion that could potentially be biopsied. A
percutaneous coaxial technique was used for 19 biopsies and a transanal non-coaxial biopsywas performed in 1. Amedian of 9 (range:
2–15) cores of tissue was obtained at each biopsy. The technical success rate and adequacy of diagnostic yield were 100%. The most
common diagnosis was lymphoma, which occurred in 16 biopsies. Three biopsies contained mucosa. There was one complication out
of 20 biopsies (5%, 95% confidence interval 0–15%): a self-limiting, post biopsy pyrexia. Nineteen procedures were accompanied by a
bone marrow aspirate and/or trephine within 2 weeks of the bowel biopsy, only one of which was diagnostic.
Conclusion US-guided bowelmass biopsy can be performed safely in children, with a high diagnostic yield and low complication rate.
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Introduction
Traditionally, biopsies of masses arising from the bowel in
children are performed endoscopically or surgically, via a lap-
arotomy or laparoscopic approach.
The main limitation of performing an endoscopic biopsy
of a bowel mass is that the reach of the endoscope is lim-
ited to the portions of the gastrointestinal tract between the
mouth and the duodenojejunal flexure and between the
rectum and the terminal ileum. Consequently, a bowel
mass anywhere from the duodenojejunal flexure to the ter-
minal ileum will be beyond the reach of an endoscopic
biopsy. Furthermore, endoscopic biopsies are largely lim-
ited to the mucosa and submucosa and so intramural,
subserosal or exophytic lesions may not be adequately
sampled [1]. In such cases, endoscopic ultrasound (US)-
guided biopsies may be considered. Endoscopic US, how-
ever, is also restricted by limited access to the small bowel
beyond the duodenojejunal flexure. Surgical biopsies of
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bowel masses are not limited by location of the lesion but
are invasive and have an associated morbidity [2–4].
A percutaneous US-guided approach is an alternative biop-
sy method. This technique has been described in adults and
demonstrated to be both safe and effective [5] but has not
previously been described in children. We hypothesise that
US-guided biopsy of bowel masses may provide a valid alter-
native diagnostic approach for children in whom specimens
suitable for histology cannot be easily obtained by endoscopy
or other methods. The aim of this study was to report our
technique and assess the diagnostic accuracy and safety of
US-guided biopsy of bowel masses in children.
Materials and methods
This single-centre retrospective study was exempted from in-
stitutional review board approval. Data were collected from a
single paediatric hospital with a well-established intervention-
al radiology programme. Patients were identified from a pro-
spectively maintained interventional radiology database of bi-
opsies. Inclusion criteria were all patients 0–18 years of age
who underwent percutaneous or transanal US-guided biopsy
of a bowel mass from June 2004 to January 2018. There were
no exclusion criteria. Data sources included the radiology in-
formation system picture archiving and communication sys-
tem, interventional radiology databases and electronic patient
records.
Demographics recorded included patient age, weight at the
time of biopsy and gender. Pre-procedural imaging findings,
biopsy technique and histological result, post-procedural clin-
ical course and imaging, and complications were recorded.
Complications were graded according to the Society of
Interventional Radiology classification of complications [6].
To assess whether a diagnosis could have been achieved by
another method, the results of any bone marrow aspirates and
trephines within a 2-week period and any endoscopic or sur-
gical bowel biopsies within a month were recorded. Data were
reviewed by two of the study investigators K.M., P.A.P who
have 2 and 5 years of post-fellowship experience, respectively.
Definitions and criteria
Technical success was defined as acquiring tissue from the
bowel mass using a US-guided biopsy technique. The pri-
mary endpoint of clinical success was defined as an ade-
quate diagnostic yield for a definitive histopathological di-
agnosis to be made. The secondary endpoints were compli-
cation rate, type and severity, categorised using Society of
Interventional Radiology standards of practice committee
classification of complications by outcome criteria [6]. A
review of medical records up to discharge from the hospital
following the commencement of chemotherapy or up to
definitive surgical treatment was used to identify and cate-
gorise delayed complications.
Demographics, technical details and complications were
analysed using descriptive statistics. Data are presented as
median (range) unless otherwise stated. Further statistical
comparison between subgroups was not performed due to
the small sample size. Ninety-five percent confidence inter-
vals (CI) were calculated for the proportion of complications.
Bowel biopsy technique
The decision to perform a US-guided biopsy of a bowel mass
was made in a multidisciplinary team meeting in conjunction
with paediatric oncologists and paediatric surgeons, and after
review of relevant prior imaging to ensure the presence of a
suitable acoustic window. Pre-biopsy complete blood count
and coagulation profile were reviewed and corrected following
consultation with the haematology department. All biopsies
were performed with the patient under general anaesthesia in
an interventional radiology suite. Pre-procedure localisation of
the bowel mass was performed with US (Logiq E9; GE
Healthcare, Waukesha, WI) and the patient positioned accord-
ingly. Depending on lesion accessibility, either a percutaneous
transabdominal or transanal route was chosen. Transabdominal
US guidance was used regardless of the approach to the lesion
(Figs. 1 and 2). Biopsies were performed using a side-notch
biopsy needle (Temno Evolution; CareFusion, San Diego, CA.
If a coaxial system was used, the tract was plugged with com-
pressed gelatin sponge pledgets (Gelfoam; Pfizer, New York,
NY). Biopsy samples were delivered fresh for histopathological
assessment (Fig. 3). No specific protocol was in place regarding
the periprocedural administration of antibiotics; the decision to
give antibiotics was at the discretion of the interventional
radiologist.
Results
Patient population
Over a 14-year period, 20 US-guided bowel mass biopsies
were performed in 19 children. Patient characteristics are giv-
en in Table 1. In 14 procedures, there was no other potential
lesion available for biopsy. In the six procedures where there
was a synchronous lesion that could have been biopsied, the
multidisciplinary team agreed that the bowel mass was the
safest to biopsy and/or most likely to give a diagnostic result.
One patient underwent 2 biopsies 11 weeks apart due to the
recurrence of the lesion. Of the 20 biopsies performed, the
review of pre-procedural imaging suggested 16 were of le-
sions arising from the small bowel and 4 were of lesions aris-
ing from the large bowel.
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Technique
Nineteen of the 20 procedures were performed using a percuta-
neous transabdominal approach. A 15-gauge outer coaxial nee-
dle and 16-gauge biopsy needle were used for 14/19 (74%) bi-
opsies and a 17-gauge outer coaxial needle and 18-gauge biopsy
needle for 5/19 (26%). All percutaneous biopsies were followed
by embolisation of the biopsy tract with compressed gelatin
sponge pledgets (Figs. 1 and 3).One biopsywas performed using
a transanal approach with a 14-gauge biopsy needle (Fig. 2) and
no subsequent tract embolisation was performed. This biopsy
was of a mass arising from the rectum, which could not be
accessed percutaneously due to the overlying urinary bladder.
The number of tissue cores obtained at each biopsy ranged from
2 to 15, with a median of 9. For 6/20 (30%) procedures, the child
was already on a course of antibiotics for preexisting pyrexia at
the time of biopsy. For the remaining 14 procedures, antibiotics
were administered intra-procedurally in 1/14 (7%) procedures
and not administered in 13/14 (93%) procedures.
Outcomes
US-guided biopsy of the bowel mass was technically success-
ful in all procedures. All biopsies yielded an adequate diag-
nostic yield to allow a histopathological diagnosis to be made
(Fig. 3). The histological diagnoses are listed in Table 1. No
repeat biopsies were required to obtain further immunohisto-
chemical information. Three out of 20 (15%) biopsies per-
formed included mucosa on histological examination infer-
ring that there was mucosal breach in at least 3 biopsies.
Of the 19 patients who underwent US-guided bowel mass
biopsy, 2 had undergone endoscopic biopsy less than 4 weeks
before their radiologic biopsy. Histology from both endoscop-
ic biopsies demonstrated focal active colitis only. On the sub-
sequent US-guided biopsy, one of these lesions was diagnosed
as diffuse large B cell lymphoma and the second as necrotising
granulomatous inflammation. No patients had a surgical biop-
sy before or after the US-guided biopsy.
Bone marrow aspiration or trephine biopsy was performed
within 14 days of 19/20 US-guided bowel mass biopsies.
Only 1/19 (5%) showed marrow involvement by the disease
process (Burkitt lymphoma); this diagnosis was consistent
with the radiologic biopsy result. One out of 19 (5%) showed
marrow infiltration by malignant cells but did not give a def-
inite diagnosis, 5/19 (26%) showed reactive marrow changes
only and 12/19 (64%) were normal.
Complications
In the period of follow-up assessed (median: 45 days, range:
2–176 days), there was 1 complication out of 20 biopsies (5%,
95% CI: 0–15%). This was a self-limiting post-biopsy pyrexia
Fig. 1 Transabdominal biopsy of
a large bowel mass in a 3-year-old
boy presenting with a scrotal mass
and subsequently found to have
synchronous bowel and testicular
lesions. Coronal (a) and axial (b)
pre-biopsy MRI demonstrate a
bowel wall-based mass (star).
Intra-procedural ultrasound (c)
shows the biopsy needle in situ
(arrow) adjacent to gas and fluid-
filled lumen (arrowhead). Tract
embolisation (d) with echogenic
absorbable gelatin sponge
(arrowhead).
The histopathological diagnosis
was Burkitt lymphoma
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that lasted for less than 24 h in a patient who was not on
antibiotics before their biopsy and was not given intra-
procedural antibiotics. This was the patient in whom a
transanal biopsy was performed. There was no mucosa found
on histological analysis of the sample. This corresponds to a
minor A complication with no therapy required and no con-
sequence, according to the Society of Interventional
Radiology classification. Three other children were docu-
mented to have had pyrexia following their biopsy, but these
children had been pyrexial before biopsy, and had been started
on a course of antibiotics for this, so this was attributed to their
underlying disease process. No patient developed a symptom-
atic or imaging-detected asymptomatic pneumoperitoneum
and no patient required surgery to treat a complication.
Discussion
Percutaneous image-guided bowel mass biopsy has been dem-
onstrated to be both safe and effective in adults [5] but has not
Fig. 3 Photomicrographs of needle core biopsies from the patient in Fig. 1.
a There is no normal underlying tissue but complete replacement by viable
tumour composed of sheets of uniform tumour cells that infiltrated
surrounding structures (haematoxylin and eosin stain: original
magnifications × 20). b On high power, the tumour shows a uniform
appearance of small ovoid cells, with focal Indian file morphology, with
lines of cells between connective tissue structures (haematoxylin and eosin
stain: original magnification × 200). c Tumour cells demonstrate diffuse
strong membrane expression of CD20 confirming, B cell origin (DAB
immunostain with haematoxylin counterstain; original magnification ×
200)
Fig. 2 Transanal biopsy in 14-year-old girl presenting with a rising lactate
dehydrogenase level following a heart transplant. Axial pre-biopsy MRI
(a) demonstrates a grossly abnormal and thickened rectum (star). Intra-
procedural ultrasound (b) using the urinary bladder filled with saline as an
acoustic window (the urinary bladder catheter balloon can be seen in the
bladder lumen) demonstrates the transanal biopsy route with a 14-gauge
biopsy needle (arrow). The histopathological diagnosis was mature large
B cell lymphoma
Pediatr Radiol
previously been described in children. Due to the small body
size of children, transabdominal US can usually be performed
using a high-frequency probe with excellent visualisation of
the abdominopelvic structures including the small and large
bowel. US provides dynamic information that cannot be ob-
tained with other imaging techniques such as CT and MRI. It
is minimally invasive, cost-effective, fast and does not require
ionising radiation. US-guided biopsy is widely used in the
diagnosis of other abdominopelvic lesions. It has high diag-
nostic accuracy, a low complication rate and lowmortality [7].
Conventionally, biopsies of lesions arising from the gastro-
intestinal tract are obtained endoscopically. The endoluminal
approach is limited to mucosal or submucosal lesions that
arise between the mouth and the duodenojejunal flexure or
between the terminal ileum and the rectum. Lesions between
the duodenojejunal flexure and the terminal ileum are gener-
ally beyond the reach of an endoscope. Furthermore, lesions
within reach of the endoscope that are intramural, subserosal
or exophytic may be impossible to visualise and/or inade-
quately sampled. In these cases, one could attempt endoscopic
US-guided fine-needle aspiration cytology or core biopsy.
Endoscopic US-guided fine-needle aspiration has a high de-
gree of sensitivity and specificity in adults [8]. Endoscopic
US-guided core biopsy is, however, better when immunohis-
tochemistry is needed, for example in submucosal tumours
and lymphoma [8]. However, like conventional endoscopy,
endoscopic US-guided biopsy is limited by poor access to
the small bowel beyond the duodenojejunal flexure and prox-
imal to the terminal ileum and is technically challenging. It has
been shown to be uniformly poor when used in certain ana-
tomical locations, such as the thickened gastrointestinal wall
or focal intramural lesions [9, 10]. Traditionally, lesions that
cannot be adequately biopsied endoscopically require a more
invasive approach such as laparoscopic or open surgical biop-
sy. A surgical approach is not limited by the location of the
lesion but is necessarily more invasive than percutaneous nee-
dle biopsy and may involve greater morbidity. Surgical biop-
sies of abdominal masses in children have a potential risk of
intraoperative and postoperative haemorrhage, delay in
initiating chemotherapy and other risks related to surgical pro-
cedures in general [2–4].
The US-guided approach is an alternative method for
obtaining samples of bowel masses for histopathological eval-
uation. Previously reported sites of percutaneous fine-needle
aspiration in adults include the stomach [1, 11, 12], small
bowel [1, 13, 14] colon [1, 14, 15] and rectum [1].
Percutaneous image-guided fine-needle aspiration of gastro-
intestinal lesions has been reported to be safe in adults [1, 14].
However, in a series of 20 adults there were 5 negative sam-
ples (showing benign colonic epithelium, benign stroma,
acute inflammation or benign lymphoid cells) [1].
We have demonstrated that US-guided biopsy of bowel
masses can be performed safely and successfully in children.
The location of the lesion does not appear to preclude a US-
guided approach. Only one mass, arising from the rectum, was
thought to be unsafe to biopsy using a transabdominal approach
due to the overlying urinary bladder, but it was successfully
biopsied using a transanal approach and transabdominal US
guidance.
In the vast majority of these cases, the underlying patho-
logical process is essentially homogeneous diffuse disease,
such as lymphoma and post-transplant lymphoproliferative
disease, and the precise site of biopsy is of no particular rele-
vance for establishing or staging the disease. Due to the ho-
mogenous nature and diagnostic immunohistochemical pro-
file of most of these disease processes, provided at least some
viable tissue is present, the amount of material required is very
small. This is in contrast to a biopsy of a lymph node, for
example, where there may be only focal involvement; here,
the amount of material and specific site of biopsy are of much
greater relevance [16]. In this series, masses arose from the
small and large bowel. A definitive clinical diagnosis was
made from all biopsies in this series.
There was only one minor (Society of Interventional
Radiology category A) complication of a self-limiting, post-
biopsy pyrexia suggesting that the procedure is safe. This case
of pyrexia followed the transanal biopsy when pre- or intra-
procedural prophylactic antibiotics were not administered.
Table 1 Patient characteristics
Patients, n 19
Biopsies, n 20
Age at biopsy, median (range) 6 years, 6 months
(1 year, 10 months–17 years)
Weight at biopsy, kg, median (range) 22 (10.2–48.4)
Gender (male), n (%) 16 (84.2)
Diagnosis from each biopsy, n (%)
Burkitt lymphoma 11 (55)
Diffuse large B cell lymphoma 5 (25)
Post-transplant lymphoproliferative disease 3 (15)
Necrotising granulomatous inflammation 1 (5)
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There were at least three percutaneous biopsies in which the
bowel mucosa was breached without any complication. These
mucosal breaches were non-intentional, and therefore this pro-
cedure should be considered “clean contaminated” according
to the Society of Interventional Radiology Standards of
Practice [17]. Given that bowel mass biopsies can be consid-
ered a clean contaminated procedure, and that patients may
become immunocompromised with subsequent treatment, an
argument could be made for the use of prophylactic antibi-
otics. Against this, the low frequency of complications in chil-
dren who did not receive pre- or intra-procedural antibiotics
would suggest that the need for antibiotic prophylaxis should
be based on an individual patient’s risk factors.
All patients in our study population were inpatients, but given
the absence of anymajor complications it is possible that patients
could undergo this procedure during a single-day admission.
All procedures in this series yielded a definitive diagnosis and
all but one proved to be an aggressive haematological process
(lymphoma or post-transplant lymphoproliferative disease). All
of these patients were treated medically and did not require sur-
gery, and so US-guided biopsy avoided laparotomy or laparos-
copy. Only one patient in the series, in whom the biopsy diag-
nosed a necrotising granulomatous inflammatory lesion, went on
to have an elective laparotomy and left hemicolectomy 8 days
after biopsy for surgical resection of this mass.
Of the 20 cases in this series, 2 had a prior endoscopic
biopsy showing only inflammatory changes of colitis. In these
two patients, the subsequent US-guided biopsy showed dif-
fuse large B cell lymphoma and a necrotising granulomatous
inflammatory lesion. If US-guided biopsy had not been per-
formed in these patients it would have delayed their diagnosis
and management and possibly increased their morbidity.
Bone marrow aspirate has routinely been performed as part
of lymphoma staging. However, patients with early-stage dis-
ease rarely have bone marrow involvement [18]. In this series,
only 1/19 bone marrow biopsies was diagnostic (Burkitt lym-
phoma) and this was consistent with the diagnosis made on
the US-guided biopsy. The remaining 18/19 bone marrow
aspirates were nondiagnostic. This shows that the diagnostic
yield from bone marrow aspirate and/or trephine biopsy is
inferior to US-guided biopsy of the bowel mass, most likely
because there is not involvement of the marrow by the disease
process. In these cases, without performance of a biopsy of the
bowel mass, a diagnosis would not have been achieved.
This study has several limitations. It is a retrospective re-
view of patients in whom a biopsy was attempted. Patients for
whom a US-guided biopsy of a bowel wall mass was request-
ed but not performed after review of available diagnostic im-
aging (CT, MRI and US) because it was thought to be not
technically feasible, and were not included. Therefore, no at-
tempt to assess the proportion of bowel masses that may be
suitable for this technique can be made. The nature and loca-
tion of lesions biopsied were not recorded such that useful
data regarding lesion location that may be suitable for US-
guided biopsy could be obtained. If conducting a prospective
assessment, this information would be useful. There were no
cases in which the core biopsies obtained were inadequate for
evaluation or in which significant complications arose.
However, the number of patients is small.
Conclusion
This study demonstrates that percutaneous or transanal US-
guided bowel mass biopsies in children are technically feasible.
The diagnostic yield in this study was 100% and minor compli-
cations occurred in 5%. The procedure avoids the use of more
invasive techniques or ionising radiation. The use of prophylactic
antibiotics remains controversial. This technique could be con-
sidered the first option for diagnosing bowel masses that can be
visualised on US, or as an alternative when an endoluminal ap-
proach is not possible or has not provided definitive results.
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